Search

Search Results

• Azacitidine/Venetoclax Combination as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemias: A First Step

  M.A. Granatkin, Evgenii Aleksandrovich Nikitin, E.S. Mikhailov, V.A. Doronin, S.V. Minenko, M.M. Okuneva, N.V. Degtyareva, M.E. Pochtar, S.A. Lugovskaya, Yu.N. Kobzev, O.Yu. Vinogradova, V.V. Ptushkin

  282-288

  01.07.2022

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Preventive Use of Azacitidine in Patients with Acute Myeloid Leukemia after Haploidentical Allo-BMT

  R.Sh. Badaev, D.B. Zammoeva, L.L. Girshova, D.V. Babenetskaya, N.A. Il’ina, Yu.A. Alekseeva, A.Yu. Zaritskey, Dmitrii Vasil’evich Motorin

  37-42

  01.01.2019

• The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, A.A. Osipova, T.L. Gindina, A.I. Shakirova, T.A. Bykova, A.D. Kulagin, I.A. Samorodova, E.V. Karyakina, E.A. Ukrainchenko, L.S. Zubarovskaya, B.V. Afanas’ev

  351-357

  01.07.2017

• Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

  Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, O.A. Slesarchuk, A.G. Smirnova, O.S. Uspenskaya, Ya.V. Gudozhnikova, A.A. Osipova, V.S. Sergeev, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev

  45-51

  01.01.2017

• Hypomethylating Agents in Oncohematology

  Anton Dmitrievich Shirin, O.Yu. Baranova

  369-382

  01.10.2016

• Hematological Improvement is a Favorable Response to Azacitidine in Patients with Acute Myeloid Leukemias and Myelodysplastic Syndromes

  Ivan Ivanovich Kostroma, S.V. Gritsaev, E.V. Karyagina, A.S. Nizamutdinova, I.S. Martynkevich, K.M. Abdulkadyrov

  413-419

  01.10.2015

• Stable donor hematopoiesis reconstitution after post-transplantation relapse of acute myeloid leukemia in patient with inv(3)(q21q26), –7 and EVI1 oncogene overexpression treated by donor lymphocyte infusions and hypomethylating agents

  N.N. Mamaev, A.V. Gorbunova, T.L. Gindina, O.A. Slesarchuk, V.N. Ovechkina, S.N. Bondarenko, O.V. Goloshchapov, V.M. Kravtsova, B.V. Afanasev

  71-75

  01.01.2014